Potassium
Chloride Injection
Category:
Description:
Indications:
Contraindications:
-
Diseases
where high potassium levels may be encountered
-
Hyperkalemia,
renal failure, potassium retention conditions
Precautions:
-
Pregnancy
category C
-
Periodic
laboratory are necessary to monitor fluid, electrolyte and
acid-base balances
-
Guide
therapy via electrocardiograms, especially in digitalis patients
-
Serum
potassium levels not necessarily indicative of tissue potassium
levels
Adverse
Reactions (Side Effects):
-
Fever,
infection at injection site, venous thrombosis
-
Extravasation,
phlebitis, hypervolemia, hyperkalemia
-
Nausea,
vomiting, abdominal pain
|
Dosage:
Administered
intravenously ONLY
Potassium
Chloride for Injection Concentrate must be diluted before administration.
Care must be taken to ensure there is complete
mixing of the potassium chloride with the large volume fluid, particularly
if soft or bag type containers are used.
-
If
serum potassium level > 2.5 mEq/L, administer at a rate not to
exceed 10 mEq/hour in a concentration up to 40 mEq/L. Max dose 200 mEq/day.
-
If
serum potassium level < 2.0 mEq/L (urgent) with electrocardiograph
changes and/or muscle paralysis, potassium chloride may be
administered at a rate up to 40 mEq/hour. Continuous cardiac
monitoring is essential. Max
dose 400 mEq/day.
Signs
and Symptoms of Potassium Intoxication:
Intoxication
may include
-
paresthesias
of the extremities
-
areflexia,
muscular or respiratory paralysis
-
mental
confusion
-
weakness
-
hypotension
-
cardiac
arrhythmias
-
heart
block
-
electrocardiographic
abnormalities
-
cardiac
arrest.
|
Home
· Military Medicine
· Sick Call · Basic Exams
· Medical Procedures
· Lab and X-ray · The Pharmacy
· The Library · Equipment
· Patient Transport
· Medical Force
Protection · Operational Safety · Operational
Settings · Special
Operations · Humanitarian
Missions · Instructions/Orders · Other Agencies · Video Gallery
· Forms · Web Links · Acknowledgements
· Help · Feedback Approved for public release;
Distribution is unlimited. The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.
Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.
Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300 |
Operational Medicine
Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
January 1, 2001 |
United States Special Operations
Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323 |
*This web version is provided by The Brookside Associates, LLC. It contains
original contents from the official US Navy NAVMED P-5139, but has been
reformatted for web access and includes advertising and links that were not
present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the
Department of the Navy or the Department of Defense. The presence of any
advertising on these pages does not constitute an endorsement of that product or
service by either the US Department of Defense or the Brookside Associates. The
Brookside Associates is a private organization, not affiliated with the United
States Department of Defense.
© 2015, Brookside Associates, LLC. All rights reserved
Other Brookside Products
|
|